Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-007642

Senior VP - CMO sold 41,250 shares at $11.57 ($477,263)

  • Senior VP - CMO acquired 41,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Sheridan William P · Senior VP - CMO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-22 Exercise or conversion : show line 1 in the form +41,250 $4.15 $171,188 52,725 D
2021-02-22 Sale : show line 2 in the form −41,250 $11.57 $477,263 11,475 D
Open-market sales · 41,250 sh · avg $11.57 · $477,263

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-22 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −41,250 0 D
Loading xslF345X03/form4.xml…